AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 87 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $81,000 | -64.0% | 33 | 0.0% | 0.00% | – |
| Q1 2022 | $225,000 | -88.4% | 33 | -86.2% | 0.00% | – |
| Q4 2021 | $1,939,000 | -97.5% | 240 | -96.9% | 0.00% | -100.0% |
| Q3 2021 | $76,653,000 | +26.7% | 7,822 | -12.1% | 0.02% | +28.6% |
| Q2 2021 | $60,519,000 | -24.8% | 8,900 | 0.0% | 0.01% | -39.1% |
| Q1 2021 | $80,452,000 | +35.3% | 8,900 | 0.0% | 0.02% | +35.3% |
| Q4 2020 | $59,449,000 | +32.5% | 8,900 | 0.0% | 0.02% | +30.8% |
| Q3 2020 | $44,854,000 | -37.6% | 8,900 | 0.0% | 0.01% | -31.6% |
| Q2 2020 | $71,910,000 | – | 8,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
| Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
| JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
| FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
| KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
| Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
| Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
| HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |